Michael Nichols

Dr. Michael Nichols is a Professor and Director of the Biochemistry and Biotechnology Program at the University of Missouri–St. Louis (UMSL). He holds a B.S. from Lindenwood College and a Ph.D. from Purdue University. His postdoctoral training at the Mayo Clinic in Jacksonville, FL, focused on biophysical analysis of proteins.

His research interests center on Alzheimer’s Disease, with a focus on amyloid-beta aggregation mechanisms, protein biophysics, cellular signaling, and inflammatory pathways. Key techniques include chromatography, light scattering, microscopy (atomic force, confocal), and cell culture studies. Dr. Nichols explores how amyloid-beta species interact with microglia and their role in neuroinflammation, with implications for therapeutic interventions.

His research output spans over 30 peer-reviewed articles, emphasizing structural biology of amyloid proteins, inflammasome activation, and protein aggregation dynamics. Notable trends include investigations into protofibril conformation effects, microglial response modulation, and novel antibody development targeting amyloid species.

No scientific awards or grants are explicitly listed in the provided text. Dr. Nichols advises students through his role in the Biochemistry and Biotechnology Program but no specific advisee names are provided.